News

Merck & Co. Inc. stock outperforms competitors on strong trading day
Merck & Co. Inc. closed 41.19% below its 52-week high of $134.63, which the company reached on June 25th.
MRK Lawsuit Alert! Class Action Lawsuit Against Merck & Company
A class action lawsuit was filed against Merck & Co. (MRK) by Levi & Korsinsky on February 12, 2025. The plaintiffs ...
The Chinese CEO Who Believes Her Cancer Drug Can Beat Merck’s Bestseller
Michelle Xia represents a rising generation of biotech companies in China challenging Western giants.
Fierce Pharma13h
Bristol Myers combo follows Roche, AstraZeneca immunotherapy rivals into first-line liver cancer
Bristol Myers Squibb has received the FDA’s green light to introduce another immunotherapy-based treatment in first-line ...
Daiichi Sankyo: Good Diversification Tool For U.S. Investors
Daiichi Sankyo Company, Limited leads in ADC tech with Enhertu, strong partnerships, revenue growth, and global market leadership. Click to know more on why DSNKY is a Buy.
China's retaliatory tariffs: here are the main U.S. exports to China made in New Jersey
To name a few, Johnson & Johnson, Merck & Co., and Bristol Myers Squibb are all top NJ-based industry names with broad export ...
Explore more
MarketWatch16h
Merck & Co. Inc.
SEC Filings provided by EDGAR Online, Inc.
Q&A: How Trump’s Plans for Pharma Tariffs Will Affect Drug Prices in the U.S.
While Trump has been wildly inconsistent on his plans for reciprocal tariffs, levies on imported pharmaceuticals appear to be ...